• Publications
  • Influence
Cytomegalovirus Replication Kinetics in Solid Organ Transplant Recipients Managed by Preemptive Therapy
After allotransplantation, cytomegalovirus (CMV) may be transmitted from the donor organ, giving rise to primary infection in a CMV negative recipient or reinfection in one who is CMV positive. InExpand
  • 120
  • 11
  • PDF
Hepatic granulomas: a 10 year single centre experience
Background: Epithelioid granulomas have been reported in 2–15% of unselected liver biopsies, with numerous underlying aetiologies described. However, all UK series were reported before identificationExpand
  • 131
  • 9
  • PDF
Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial
Summary Background Cytomegalovirus end-organ disease can be prevented by giving ganciclovir when viraemia is detected in allograft recipients. Values of viral load correlate with development ofExpand
  • 292
  • 8
The UK‐PBC risk scores: Derivation and validation of a scoring system for long‐term prediction of end‐stage liver disease in primary biliary cholangitis
The biochemical response to ursodeoxycholic acid (UDCA)—so‐called “treatment response”—strongly predicts long‐term outcome in primary biliary cholangitis (PBC). Several long‐term prognostic modelsExpand
  • 143
  • 6
  • PDF
Treatment for mitochondrial disorders.
BACKGROUND Mitochondrial respiratory chain disorders are the most prevalent group of inherited neurometabolic diseases. They present with central and peripheral neurological features usually inExpand
  • 107
  • 6
Is interferon‐alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case–control study
Background:  Hepatitis C virus infection is more common in patients with inflammatory bowel disease than in general population. Limited data are available as to the safety and efficacy ofExpand
  • 43
  • 3
Endoscopic versus percutaneous drainage of symptomatic pancreatic fluid collections: a 14-year experience from a tertiary hepatobiliary centre
AbstractIntroduction Endoscopic transmural drainage (ED) or percutaneous drainage (PD) has mostly replaced surgery for the initial management of patients with symptomatic pancreatic fluid collectionsExpand
  • 39
  • 3
  • PDF
Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and Outcome
Objectives:In this era of near universal ursodeoxycholic acid (UDCA) treatment for primary biliary cholangitis (PBC), progression to cirrhosis still occurs in an important proportion of patients. TheExpand
  • 29
  • 2
Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort
Several prognostic models have emerged in alcoholic hepatitis (AH), but lack of external validation precludes their universal use.
  • 47
  • 2
Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease.
BACKGROUND & AIMS The development of non-invasive liver fibrosis tests may enable earlier identification of patients with non-alcoholic fatty liver disease (NAFLD) requiring referral to secondaryExpand
  • 47
  • 2
  • PDF